Which therapy target is involved in decreasing the risk of cancer recurrence?

Adjuvant therapy is specifically designed to reduce the risk of cancer recurrence after the primary treatment, such as surgery. This approach typically involves the use of chemotherapy, radiation, or hormonal therapy following the removal of the tumor to eliminate any remaining cancer cells that may not be detectable but could lead to relapse. The intent is to improve the overall outcomes for patients by addressing potential microscopic disease.

In contrast, neoadjuvant therapy refers to treatments given before the primary surgery to shrink tumors, making them easier to remove, but it does not directly target recurrence after surgery. Conditioning therapy mainly prepares a patient for more aggressive treatments like stem cell transplants and is not focused on preventing recurrence. Palliative therapy aims to relieve symptoms and improve quality of life for patients with advanced cancer and does not incorporate strategies to decrease the risk of recurrence. Therefore, adjuvant therapy is the most appropriate choice, as it directly addresses the prevention of cancer recurrence post-surgery.